東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back to Search results for [ null ]

Switch To: Labeled | MARC Mode | ISBD

Fighting the opioid epidemic = the r...

Dasgupta, Amitava, (1958-)

Linked to FindBook

Google Book

Amazon

博客來

Fighting the opioid epidemic = the role of providers and the clinical laboratory in understanding who is vulnerable /

Record Type:	Electronic resources : Monograph/item
Title/Author:	Fighting the opioid epidemic/ Amitava Dasgupta.
Reminder of title:	the role of providers and the clinical laboratory in understanding who is vulnerable /
Author:	Dasgupta, Amitava,
Published:	Amsterdam, Netherlands ;Elsevier, : 2020.,
Description:	1 online resource (ix, 149 p.) :ill.
[NT 15003449]:	Front Cover -- Fighting the Opioid Epidemic: The Role of Providers and the Clinical Laboratory in Understanding Who is Vulnerable -- Fighting the Opioid Epidemic: The Role of Providers and the Clinical Laboratory in Understanding Who is Vulnerable -- Copyright -- Dedication -- Preface -- Contents -- 1 -- Crude Opium, Morphine, Codeine, and Heroin: Past and Present -- INTRODUCTION -- OPIUM USE: FROM ANCIENT TIME TO MODERN TIME -- OPIUM AND POPPY PLANTS: LEGAL ISSUES --ALKALOIDS FOUND IN OPIUM -- MORPHINE -- CODEINE AND THEBAINE -- HEROIN -- Heroin Synthesis and Cutting of Heroin
[NT 15003449]:	White versus Brown and Black Tar Heroin -- Heroin Laced with Fentanyl -- Heroin Pharmacokinetics -- Adverse Effects of Heroin -- BLOOD AND URINE LEVELS OF HEROIN AND ITS METABOLITES -- Treatment of Heroin Overdose and Heroin Withdrawal -- CONCLUSIONS -- REFERENCES -- 2 -- Prescription Opioids: An Overview -- INTRODUCTION -- HISTORY OF PAIN MANAGEMENT -- OPIOID RECEPTORS -- PRESCRIPTION OPIOIDS -- Opioid Prescription Pattern -- MORPHINE -- CODEINE -- Oxycodone -- HYDROCODONE -- HYDROMORPHONE -- OXYMORPHONE -- FENTANYL -- Fentanyl Derivatives -- METHADONE -- MEPERIDINE -- TRAMADOL -- TAPENTADOL
[NT 15003449]:	BUPRENORPHINE -- LEVORPHANOL -- PROPOXYPHENE -- EFFECT OF SEX, AGE, ETHNICITY, AND REANAL AND HEPATIC FUNCTION ON CERTIN OPIOIDS -- OTHER OPIOIDS -- ABUSE-DETERRENT OPIOID FORMULATIONS -- Physical/Chemical Barrier Technology -- Combining an Opioid Drug with an Opioid Antagonist -- Incorporation of Aversive Ingredients -- Abuse-Deterrent Prodrug Formulation -- Novel Drug Delivery System -- COMPLIANCE WITH PRESCRIPTION OPIOID -- CONCLUSIONS -- REFERENCES -- 3 -- Opioid Abuse and Opioid Epidemic -- INTRODUCTION -- ANALGESIC LADDER PROPOSED BY THE WORLD HEALTH ORGANIZATION
[NT 15003449]:	OTHER GUIDELINES IN PAIN MANAGEMENT -- OPIOID ABUSE AND OPIOID-RELATED FATALITIES -- WHAT CAUSED OPIOID EPIDEMIC? -- Heroin Laced With Fentanyl and Fatality -- WHICH OPIOIDS ARE MOST COMMONLY ABUSED? -- Oxycodone Abuse -- Oxymorphone Abuse -- Hydrocodone or Hydromorphone Abuse -- Morphine or Codeine Abuse -- Fentanyl Abuse -- Other Abused Opioids -- COMBINED ABUSE OF OPIOIDS, OTHER DRUGS, AND ALCOHOL: A DEADLY COMBINATION -- PRESCRIPTION MONITORING -- CONCLUSIONS -- REFERENCES -- 4 -- Genetic Factors Associated With Opioid Therapy and Opioid Addiction -- INTRODUCTION
[NT 15003449]:	SUBSTANCE ABUSE DISORDER: ROLE OF GENE AND ENVIRONMENT -- DRUG-METABOLIZING ENZYMES -- CYP FAMILY OF ENZYMES -- Polymorphism of CYP2D6 -- Polymorphism of CYP2B6 -- Polymorphism of CYP2C9 -- Polymorphisms of Other CYP Isoenzymes -- POLYMORPHISMS OF CYP2D6 AND OPIOID THERAPY -- CYP2D6 Gene Polymorphism and Codeine Therapy -- CYP2D6 Gene Polymorphism and Tramadol Therapy -- CYP2D6 Gene Polymorphism and Therapy with Oxycodone or Hydrocodone -- Methadone toxicity and pharmacogenetics issues -- Morphine and pharmacogenetic considerations -- Hydromorphone and pharmacogenomics
[NT 15003449]:	Pharmacogenomics issues with fentanyl
Subject:	Opioid abuse. -
Online resource:	https://www.sciencedirect.com/science/book/9780128200759
ISBN:	9780128223901 (electronic bk.)

Fighting the opioid epidemic = the role of providers and the clinical laboratory in understanding who is vulnerable /
Dasgupta, Amitava,1958-

Fighting the opioid epidemicthe role of providers and the clinical laboratory in understanding who is vulnerable /[electronic resource] :Amitava Dasgupta. - Amsterdam, Netherlands ;Elsevier,2020. - 1 online resource (ix, 149 p.) :ill.

Includes bibliographical references and index.

Front Cover -- Fighting the Opioid Epidemic: The Role of Providers and the Clinical Laboratory in Understanding Who is Vulnerable -- Fighting the Opioid Epidemic: The Role of Providers and the Clinical Laboratory in Understanding Who is Vulnerable -- Copyright -- Dedication -- Preface -- Contents -- 1 -- Crude Opium, Morphine, Codeine, and Heroin: Past and Present -- INTRODUCTION -- OPIUM USE: FROM ANCIENT TIME TO MODERN TIME -- OPIUM AND POPPY PLANTS: LEGAL ISSUES --ALKALOIDS FOUND IN OPIUM -- MORPHINE -- CODEINE AND THEBAINE -- HEROIN -- Heroin Synthesis and Cutting of Heroin

ISBN: 9780128223901 (electronic bk.)Subjects--Topical Terms:

2157981
Opioid abuse.
Index Terms--Genre/Form:

542853
Electronic books.

LC Class. No.: RC568.O45 / D37 2020

Dewey Class. No.: 362.29/3

National Library of Medicine Call No.: WM 284

Fighting the opioid epidemic = the role of providers and the clinical laboratory in understanding who is vulnerable /
LDR:04133cmm a2200337 a 4500 001 2246301
006 m o d
007 cr un|---aucuu
008 211223s2020 ne a gob 001 0 eng d
020 $a 9780128223901 (electronic bk.)
020 $a 0128223901 (electronic bk.)
020 $a 9780128200759
020 $a 0128200758
035 $a (OCoLC)1178634727
035 $a on1178634727
040 $a EBLCP $b eng $c EBLCP $d YDX $d OPELS $d YDXIT $d OCLCO $d UKAHL $d N$T $d OCLCF $d OCLCA
041 0 $a eng
050 4 $a RC568.O45 $b D37 2020
060 4 $a WM 284
082 0 4 $a 362.29/3 $2 23
100 1 $a Dasgupta, Amitava, $d 1958- $e author. $3 3398089
245 1 0 $a Fighting the opioid epidemic $h [electronic resource] : $b the role of providers and the clinical laboratory in understanding who is vulnerable / $c Amitava Dasgupta.
260 $a Amsterdam, Netherlands ; $a Cambridge, MA : $b Elsevier, $c 2020.
300 $a 1 online resource (ix, 149 p.) : $b ill.
504 $a Includes bibliographical references and index.
505 8 $a Front Cover -- Fighting the Opioid Epidemic: The Role of Providers and the Clinical Laboratory in Understanding Who is Vulnerable -- Fighting the Opioid Epidemic: The Role of Providers and the Clinical Laboratory in Understanding Who is Vulnerable -- Copyright -- Dedication -- Preface -- Contents -- 1 -- Crude Opium, Morphine, Codeine, and Heroin: Past and Present -- INTRODUCTION -- OPIUM USE: FROM ANCIENT TIME TO MODERN TIME -- OPIUM AND POPPY PLANTS: LEGAL ISSUES --ALKALOIDS FOUND IN OPIUM -- MORPHINE -- CODEINE AND THEBAINE -- HEROIN -- Heroin Synthesis and Cutting of Heroin
505 8 $a White versus Brown and Black Tar Heroin -- Heroin Laced with Fentanyl -- Heroin Pharmacokinetics -- Adverse Effects of Heroin -- BLOOD AND URINE LEVELS OF HEROIN AND ITS METABOLITES -- Treatment of Heroin Overdose and Heroin Withdrawal -- CONCLUSIONS -- REFERENCES -- 2 -- Prescription Opioids: An Overview -- INTRODUCTION -- HISTORY OF PAIN MANAGEMENT -- OPIOID RECEPTORS -- PRESCRIPTION OPIOIDS -- Opioid Prescription Pattern -- MORPHINE -- CODEINE -- Oxycodone -- HYDROCODONE -- HYDROMORPHONE -- OXYMORPHONE -- FENTANYL -- Fentanyl Derivatives -- METHADONE -- MEPERIDINE -- TRAMADOL -- TAPENTADOL
505 8 $a BUPRENORPHINE -- LEVORPHANOL -- PROPOXYPHENE -- EFFECT OF SEX, AGE, ETHNICITY, AND REANAL AND HEPATIC FUNCTION ON CERTIN OPIOIDS -- OTHER OPIOIDS -- ABUSE-DETERRENT OPIOID FORMULATIONS -- Physical/Chemical Barrier Technology -- Combining an Opioid Drug with an Opioid Antagonist -- Incorporation of Aversive Ingredients -- Abuse-Deterrent Prodrug Formulation -- Novel Drug Delivery System -- COMPLIANCE WITH PRESCRIPTION OPIOID -- CONCLUSIONS -- REFERENCES -- 3 -- Opioid Abuse and Opioid Epidemic -- INTRODUCTION -- ANALGESIC LADDER PROPOSED BY THE WORLD HEALTH ORGANIZATION
505 8 $a OTHER GUIDELINES IN PAIN MANAGEMENT -- OPIOID ABUSE AND OPIOID-RELATED FATALITIES -- WHAT CAUSED OPIOID EPIDEMIC? -- Heroin Laced With Fentanyl and Fatality -- WHICH OPIOIDS ARE MOST COMMONLY ABUSED? -- Oxycodone Abuse -- Oxymorphone Abuse -- Hydrocodone or Hydromorphone Abuse -- Morphine or Codeine Abuse -- Fentanyl Abuse -- Other Abused Opioids -- COMBINED ABUSE OF OPIOIDS, OTHER DRUGS, AND ALCOHOL: A DEADLY COMBINATION -- PRESCRIPTION MONITORING -- CONCLUSIONS -- REFERENCES -- 4 -- Genetic Factors Associated With Opioid Therapy and Opioid Addiction -- INTRODUCTION
505 8 $a SUBSTANCE ABUSE DISORDER: ROLE OF GENE AND ENVIRONMENT -- DRUG-METABOLIZING ENZYMES -- CYP FAMILY OF ENZYMES -- Polymorphism of CYP2D6 -- Polymorphism of CYP2B6 -- Polymorphism of CYP2C9 -- Polymorphisms of Other CYP Isoenzymes -- POLYMORPHISMS OF CYP2D6 AND OPIOID THERAPY -- CYP2D6 Gene Polymorphism and Codeine Therapy -- CYP2D6 Gene Polymorphism and Tramadol Therapy -- CYP2D6 Gene Polymorphism and Therapy with Oxycodone or Hydrocodone -- Methadone toxicity and pharmacogenetics issues -- Morphine and pharmacogenetic considerations -- Hydromorphone and pharmacogenomics
505 8 $a Pharmacogenomics issues with fentanyl
588 $a Description based on online resource; title from digital title page (viewed on August 10, 2020).
650 0 $a Opioid abuse. $3 2157981
650 2 $a Opioid Epidemic. $3 3509625
650 2 $a Opioid-Related Disorders. $3 806855
650 7 $a Opioid abuse $2 fast $3 3509626
655 4 $a Electronic books. $2 lcsh $3 542853
856 4 0 $u https://www.sciencedirect.com/science/book/9780128200759